In Clark et al. (2017) 1 figure legends for figure 5 and 6 were incorrectly published on pages 581-582.
. Impaired FXN processing from FXN to FXN 81-210 occurs in fibroblasts from FRDA patients with FXN G130V . FXN levels were quantified by western blot using whole cell extracts from control (CTRL), FRDA, and G130V patient fibroblasts. CTRL = 5 fibroblast lines (n = 13), G130V = 3 lines (n = 17), and Typical = 7 lines (n = 8). (A) FXN 42-210 (18 kD), and FXN 81-210 (13 kD) levels from control (CTRL), G130V, and typical FRDA were detected from whole cell extracts by western blot using an anti-FXN antibody. Detection of GAPDH serves as a loading control. FXN levels are quantified and expressed as a ratio of FXN 42-210 to FXN . (*) = P < 0.05. (B). Confocal microscopy images of patient fibroblasts (CTRL, FRDA, and G130V) that were fixed and stained using primary anti-FXN and primary antimitofusin antibodies. Secondary antibodies included Alexa Fluor 568 (FXN) and Alexa Fluor 488 (mitofusin). DAPI was also used as a nuclear stain. We apologize for these errors.
